Local Institution

Halle 06120

0 studies enrolling now · 13 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Advanced Cutaneous Melanoma, Advanced Non-small Cell Lung Cancer, Albuminuria, Atrial Fibrillation, Atrial Flutter, Carcinoma, Non-Small-Cell Lung, Congestive Heart Failure, Crohn's Disease, Crohn's Enteritis, Gastric/Esophageal Adenocarcinoma

Studies at this site

• An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease — Stopped early
• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment — Completed
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
• Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria — Completed